New stroke drug shows promise in early safety trial
NCT ID NCT06447415
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 26 times
Summary
This early-stage study tested a new drug called HRS-7450 in 64 adults who had an acute ischemic stroke (a stroke caused by a blood clot). The main goal was to see if the drug is safe and tolerable, especially regarding the risk of bleeding in the brain. Researchers also looked at whether the drug could help restore blood flow to the brain. The study was completed, but results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Sun Yat sen University
Guangzhou, Guangdong, 510062, China
Conditions
Explore the condition pages connected to this study.